Switch to:
More From Other Websites
AstraZeneca and MedImmune present positive immuno-oncology combination data at ASCO 2015 May 30 2015
Amgen Takes a Hit, Shelves Potential Blockbuster May 29 2015
At ASCO: Bristol, Merck Drugs Shrink Several Tumor Types May 29 2015
Bristol-Myers sues immunotherapy exec who left for AstraZeneca May 29 2015
What to expect from ASCO May 29 2015
Jim Cramer's Stop Trading: Lilly's AstraZeneca Partnership Is a ‘Brilliant’ Move May 29 2015
Cramer's Stop Trading: Eli Lilly May 29 2015
ASCO targets war on cancer May 29 2015
Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors May 29 2015
4 Big-Cap Beauties Trading At Unmissable Prices: AstraZeneca plc, Old Mutual plc, BAE Systems plc... May 29 2015
AstraZeneca and Lilly to test new cancer drug combination May 29 2015
AstraZeneca and Lilly to test new cancer drug combination May 29 2015
AstraZeneca and Lilly to collaborate on Immuno-oncology combination clinical trial in solid tumours May 29 2015
Medimmune and Immunocore announce new collaboration to conduct immuno-oncology combination trials in... May 28 2015
Teva pays $1.2 billion to settle pay-for-delay allegations May 28 2015
Teva pays $1.2 billion to settle pay-for-delay allegations May 28 2015
Why Pfizer's Pursuit Of AstraZeneca Continues To Shape The Outlook Of Both Companies May 28 2015
AstraZeneca announces updated progression free survival data for investigational non-small cell lung... May 27 2015
Here Is How AstraZeneca and Amgen Will Be Hit By The Cancelled Collaboration May 27 2015
Amgen, AstraZeneca End Development Pact; Shares Sink May 26 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK